Julie Hill

Track

Insider profile

Performance

Overall performance
3.5
Performance over holding periods
3.5
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 86% 68% 82%
Transactions
5 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Julie Hill's trades of Hikma Pharmaceuticals PLC's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
333.39
Quantity 89,810
Value £558,602
Transaction date
Purchase
Price
341.12
Quantity 55,246
Value £105,878
Transaction date
Purchase
Price
483.15
Quantity 93,809
Value £141,865
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-22 2026-09-21
B Purchase
89,810
333.39
£558,602 		89,810 333.39 £558,602
2026-05-06 2026-05-05
B Purchase
55,246
341.12
£105,878 		55,246 341.12 £105,878
2024-09-24 2024-09-23
B Purchase
93,809
483.15
£141,865 		93,809 483.15 £141,865
2024-05-09 2024-05-07
B Purchase
59
19.79
£1,168 		59 19.79 £1,168
2024-05-09 2024-05-03
B Purchase
1
19.34
£19 		1 19.34 £19